Showing results (11-20 of 168) with videos related to
Sort By:
Pageof 17
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 28, 2017
The current conceptualization of negative symptoms in schizophreniaStephen R Marder, Silvana GalderisiEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 27, 2013
Defining and measuring negative symptoms of schizophrenia in clinical trialsStephen R Marder, Brian KirkpatrickSchizophrenia Research|July 30, 2023
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatmentsStephen R Marder, Daniel UmbrichtPsychopharmacology|February 2, 2002
Brain, plasma and tissue pharmacokinetics of risperidone and 9-hydroxyrisperidone after separate oral administration to ratsManickam Aravagiri, Stephen R MarderSchizophrenia Research|November 9, 2004
Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophreniaStephen R Marder, Wayne FentonCurrent Psychiatry Reports|July 17, 2008
Better pharmacotherapy for schizophrenia: what does the future hold?Michael A Webber, Stephen R MarderSchizophrenia Research|December 7, 2019
Rethinking the risks and benefits of long-term maintenance in schizophreniaMichael F Zito, Stephen R MarderJournal of the American Dental Association (1939)|May 31, 2002
The psychopathology, medical management and dental implications of schizophreniaArthur H Friedlander, Stephen R MarderAnnual Review of Clinical Psychology|February 21, 2019
History of PsychopharmacologyJoel T Braslow, Stephen R MarderThe Journal of Clinical Psychiatry|May 14, 2005
Long-term maintenance therapy with quetiapine versus haloperidol decanoate in patients with schizophrenia or schizoaffective disorderIra D Glick, Stephen R MarderPageof 17